Navigation Links
Bio-Optronics bioPoint(TM) Patient ID Wristband System Enhancing Patient Safety
Date:4/27/2010

ROCHESTER, N.Y., April 27 /PRNewswire/ -- Bio-Optronics, Inc., a leader in healthcare workflow software, recently attended the American Organization of Nurse Executives (AONE) Annual Meeting in Indianapolis where it showcased its bioPoint™ Patient ID Wristband System. The customer-base for this safety-enhancing product is rapidly expanding and bioPoint™ will be exhibited again soon at the NPSF Patient Safety Congress in Orlando, Florida from May 18 to 19.

Currently, bioPoint™ is being used in over 50 VA hospitals and the wristband system sales rate more than tripled in 2008 to 2009. Its recognized and accepted enhanced safety system for patient protection ensures that the product's strong order rate continues to rise with sales both in VA and non-VA hospitals.

"It has the flexibility to interface to different back-end hospital information systems and different front-end printers and media," Bio-Optronics CEO and President Dan Kerpelman said. "We also offer flexible configurations, including client-server, client-server web and web, to meet different price and need points."

The bioPoint™ ID Wristband System provides a user-friendly interface with "WYSIWYG" design capabilities including a color-coding system that follows the American Hospital Association's recommendations for the standardization of wristband colors for safety tags. bioPoint™ can even incorporate a signature, fingerprint or other biometrics into the wristband.

With a fully customizable wristband, or with a choice of pre-populated designs, the color photographs, color-coded alerts, personalized logos and choice of barcodes, hospitals and clinics can identify patients more easily with a system that increases efficiency, reduces the potential for error and most importantly, improves patient safety.

To increase the safety of young patients and newborns especially, the Bio-Optronics bioPoint™ Wristband System allows for a link to be made between patients and other persons on the premises, including visitors, doctors and even other patients, for whom the product can seamlessly create badges using the same software, saving on time and resources.

About Bio-Optronics

Bio-Optronics develops, deploys, and operates software products and custom information technology solutions to help healthcare professionals manage and optimize workflow, thus enhancing quality, productivity, and patient and staff satisfaction.

For 25 years, Bio-Optronics has demonstrated leadership in innovation, expertise in workflow and integration, and a singular approach to unparalleled customer service.

Bio-Optronics, +1 (585) 272-1960, http://www.bio-optronics.com; Maria Durkin, VP, Director Marketing and Operations, mdurkin@bio-optronics.com


'/>"/>
SOURCE Bio-Optronics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... -- Research and Markets has announced the addition ... their offering. ... The report forecasts the global optical transceiver market to grow at ... The report covers the present scenario and the growth prospects of ... size, the report considers the revenue generated from the shipment of ...
(Date:12/9/2016)... , Dec. 9, 2016  RxWiki Inc., a ... and digital marketing strategies of thousands of pharmacies through ... won Austin Inno,s "50 on Fire" Award ... "We,re pleased to accept the award as one ... , Chief Executive Officer at RxWiki. "Our platform gives ...
(Date:12/8/2016)... 8, 2016 IRIDEX Corporation (NASDAQ: IRIX ... shares of common stock, $0.01 par value (the "Offering" with ... offering.  The final terms of the Offering will depend on ... there can be no assurance as to whether or when ... use the net proceeds it will receive from this offering ...
Breaking Medicine Technology:
(Date:12/9/2016)... New York, NY (PRWEB) , ... December 09, 2016 , ... ... that raises awareness for organ transplantation while encouraging readers to sign up as an ... for a lifesaving organ transplant. , An organ donor can save up to ...
(Date:12/9/2016)... ... 2016 , ... "I had a terrible time trying to get my grandson ... if the nebulizer had a more child-friendly design, then children would be more likely ... patent-pending NEBY to avoid the need to deliver medication via a nebulizer mask. The ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in ... and patient safety. Only a few hospitals and facilities have earned this distinction. ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... CURE Media ... centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat ... the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team ...
Breaking Medicine News(10 mins):